{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:23:17Z","timestamp":1776090197264,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is associated with chronic low-grade inflammation, which is linked to cancer development. Abdominal obesity (a body mass index, ABSI), however, has unusually been associated inversely with cutaneous malignant melanoma (CMM), while general obesity (body mass index, BMI) is associated positively. Leucocytes participate in inflammation and are higher in obesity, but prospective associations of leucocytes with cutaneous malignant melanoma are unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We examined the prospective associations of neutrophil, lymphocyte, and monocyte counts (each individually), as well as the prospective associations of ABSI and BMI, with cutaneous malignant melanoma in UK Biobank. We used multivariable Cox proportional hazards models and explored heterogeneity according to sex, menopausal status, age (\u2265\u200950 years at recruitment), smoking status, ABSI (dichotomised at the median: \u226573.5 women; \u226579.8 men), BMI (normal weight, overweight, obese), and time to diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a mean follow-up of 10.2 years, 2174 CMM cases were ascertained in 398,450 participants. There was little evidence for associations with neutrophil or lymphocyte counts. Monocyte count, however, was associated inversely in participants overall (HR\u2009=\u20090.928; 95%CI: 0.888\u20130.971; per one standard deviation increase; SD\u2009=\u20090.144*10<jats:sup>9<\/jats:sup>\/L women; SD\u2009=\u20090.169*10<jats:sup>9<\/jats:sup>\/L men), specifically in older participants (HR\u2009=\u20090.906; 95%CI: 0.862\u20130.951), and more clearly in participants with low ABSI (HR\u2009=\u20090.880; 95%CI: 0.824\u20130.939), or with BMI\u2009\u2265\u200925\u00a0kg\/m<jats:sup>2<\/jats:sup> (HR\u2009=\u20090.895; 95%CI: 0.837\u20130.958 for overweight; HR\u2009=\u20090.923; 95%CI: 0.848\u20131.005 for obese). ABSI was associated inversely in pre-menopausal women (HR\u2009=\u20090.810; 95%CI: 0.702\u20130.935; SD\u2009=\u20094.95) and men (HR\u2009=\u20090.925; 95%CI: 0.867\u20130.986; SD\u2009=\u20094.11). BMI was associated positively in men (HR\u2009=\u20091.148; 95%CI: 1.078\u20131.222; SD\u2009=\u20094.04\u00a0kg\/m<jats:sup>2<\/jats:sup>). There was little evidence for heterogeneity according to smoking status. The associations with monocyte count and BMI were retained to at least 8 years prior to diagnosis, but the association with ABSI was observed up to 4 years prior to diagnosis and not for longer follow-up time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Monocyte count is associated prospectively inversely with the risk of developing CMM in older individuals, while BMI is associated positively in men, suggesting a mechanistic involvement of factors related to monocytes and subcutaneous adipose tissue in melanoma development. An inverse association with ABSI closer to diagnosis may reflect reverse causality or glucocorticoid resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12344-0","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:02:07Z","timestamp":1716447727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective associations of leucocyte subtypes and obesity with the risk of developing cutaneous malignant melanoma in the UK Biobank cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Sofia","family":"Christakoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos K.","family":"Tsilidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"5","key":"12344_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global Burden of Cutaneous Melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160.","journal-title":"JAMA Dermatol"},{"issue":"16","key":"12344_CR2","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1002\/cam4.4097","volume":"10","author":"S Christakoudi","year":"2021","unstructured":"Christakoudi S, Tsilidis KK, Evangelou E, Riboli E. A body shape index (ABSI), hip index, and risk of cancer in the UK Biobank cohort. Cancer Med. 2021;10(16):5614\u201328. https:\/\/doi.org\/10.1002\/cam4.4097.","journal-title":"Cancer Med"},{"issue":"7","key":"12344_CR3","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts Mortality Hazard independently of body Mass Index. PLoS ONE. 2012;7(7):e39504. https:\/\/doi.org\/10.1371\/journal.pone.0039504.","journal-title":"PLoS ONE"},{"issue":"12","key":"12344_CR4","doi-asserted-by":"publisher","first-page":"e1009244","DOI":"10.1371\/journal.pgen.1009244","volume":"16","author":"R Madelaine","year":"2020","unstructured":"Madelaine R, Ngo KJ, Skariah G, Mourrain P. Genetic deciphering of the antagonistic activities of the melanin-concentrating hormone and melanocortin pathways in skin pigmentation. PLoS Genet. 2020;16(12):e1009244. https:\/\/doi.org\/10.1371\/journal.pgen.1009244.","journal-title":"PLoS Genet"},{"issue":"1","key":"12344_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0092-8674(00)81865-6","volume":"88","author":"D Huszar","year":"1997","unstructured":"Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131\u201341. https:\/\/doi.org\/10.1016\/s0092-8674(00)81865-6.","journal-title":"Cell"},{"key":"12344_CR6","doi-asserted-by":"publisher","first-page":"289645","DOI":"10.1155\/2010\/289645","volume":"2010","author":"R Monteiro","year":"2010","unstructured":"Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:289645. https:\/\/doi.org\/10.1155\/2010\/289645.","journal-title":"Mediators Inflamm"},{"issue":"35","key":"12344_CR7","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/jco.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer mechanisms: Tumor Microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270\u20136. https:\/\/doi.org\/10.1200\/jco.2016.67.4283.","journal-title":"J Clin Oncol"},{"issue":"1","key":"12344_CR8","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1038\/s41598-022-12284-4","volume":"12","author":"S Christakoudi","year":"2022","unstructured":"Christakoudi S, Riboli E, Evangelou E, Tsilidis KK. Associations of body shape index (ABSI) and hip index with liver, metabolic, and inflammatory biomarkers in the UK Biobank cohort. Sci Rep. 2022;12(1):8812. https:\/\/doi.org\/10.1038\/s41598-022-12284-4.","journal-title":"Sci Rep"},{"issue":"3","key":"12344_CR9","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"12344_CR10","unstructured":"UK Biobank Haematology Data Companion Document; 24. October 2017. URL: https:\/\/biobank.ndph.ox.ac.uk\/ukb\/ukb\/docs\/haematology.pdf(Accessed: 18\/07\/2023)."},{"key":"12344_CR11","unstructured":"UK Biobank Coordinating Centre. UK Biobank: Protocol for a large-scale prospective epidemiological resource. Protocol No: UKBB-PROT-09-06 (Main Phase); 21 March 2007 (AMENDMENT ONE FINAL). URL: https:\/\/www.ukbiobank.ac.uk\/media\/gnkeyh2q\/study-rationale.pdf(Accessed: 18\/07\/2023)."},{"issue":"1","key":"12344_CR12","doi-asserted-by":"publisher","first-page":"10774","DOI":"10.1038\/s41598-022-14439-9","volume":"12","author":"S Christakoudi","year":"2022","unstructured":"Christakoudi S, Riboli E, Evangelou E, Tsilidis KK. Associations of body shape phenotypes with sex steroids and their binding proteins in the UK Biobank cohort. Sci Rep. 2022;12(1):10774. https:\/\/doi.org\/10.1038\/s41598-022-14439-9.","journal-title":"Sci Rep"},{"issue":"1","key":"12344_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12931-023-02561-9","volume":"24","author":"S Christakoudi","year":"2023","unstructured":"Christakoudi S, Tsilidis KK, Evangelou E, Riboli E. Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort. Respir Res. 2023;24(1):249. https:\/\/doi.org\/10.1186\/s12931-023-02561-9.","journal-title":"Respir Res"},{"key":"12344_CR14","unstructured":"R Core Team. (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https:\/\/www.r-project.org(Accessed 18\/07\/2023)."},{"key":"12344_CR15","unstructured":"STATA Multiple-Imputation Reference Manual Release 13. URL: https:\/\/www.stata.com\/manuals13\/mi.pdf(Accessed 31\/10\/2023)."},{"issue":"2","key":"12344_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2307\/2532940","volume":"51","author":"M Lunn","year":"1995","unstructured":"Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51(2):524\u201332.","journal-title":"Biometrics"},{"issue":"1","key":"12344_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","volume":"20","author":"M Zhu","year":"2022","unstructured":"Zhu M, Ma Z, Zhang X, Hang D, Yin R, Feng J, et al. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and mendelian randomization analysis. BMC Med. 2022;20(1):301. https:\/\/doi.org\/10.1186\/s12916-022-02506-x.","journal-title":"BMC Med"},{"issue":"32","key":"12344_CR18","doi-asserted-by":"publisher","first-page":"13085","DOI":"10.1073\/pnas.1300314110","volume":"110","author":"A Pommier","year":"2013","unstructured":"Pommier A, Audemard A, Durand A, Lengagne R, Delpoux A, Martin B, et al. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4\u2009+\u2009T cells. Proc Natl Acad Sci U S A. 2013;110(32):13085\u201390. https:\/\/doi.org\/10.1073\/pnas.1300314110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"12344_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.147","volume":"36","author":"GA Currie","year":"1977","unstructured":"Currie GA, Hedley DW. Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors. Br J Cancer. 1977;36(1):1\u20136. https:\/\/doi.org\/10.1038\/bjc.1977.147.","journal-title":"Br J Cancer"},{"issue":"5","key":"12344_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0022-4804(82)90053-1","volume":"33","author":"EC Krishnan","year":"1982","unstructured":"Krishnan EC, Menon CD, Krishnan L, Jewell WR. Quantitative studies of monocyte maturation in patients with malignant melanoma. J Surg Res. 1982;33(5):386\u201393. https:\/\/doi.org\/10.1016\/0022-4804(82)90053-1.","journal-title":"J Surg Res"},{"issue":"5","key":"12344_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/bjc.1978.113","volume":"37","author":"DW Hedley","year":"1978","unstructured":"Hedley DW, Currie GA. Monocytes and macrophages in malignant melanoma. III. Reduction of nitroblue tetrazolium by peripheral blood monocytes. Br J Cancer. 1978;37(5):747\u201352. https:\/\/doi.org\/10.1038\/bjc.1978.113.","journal-title":"Br J Cancer"},{"key":"12344_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.exger.2018.04.008","volume":"108","author":"BD Pence","year":"2018","unstructured":"Pence BD, Yarbro JR. Aging impairs mitochondrial respiratory capacity in classical monocytes. Exp Gerontol. 2018;108:112\u20137. https:\/\/doi.org\/10.1016\/j.exger.2018.04.008.","journal-title":"Exp Gerontol"},{"issue":"5","key":"12344_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1474-9726.2012.00851.x","volume":"11","author":"AC Hearps","year":"2012","unstructured":"Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell. 2012;11(5):867\u201375. https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00851.x.","journal-title":"Aging Cell"},{"issue":"3","key":"12344_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/COC.0b013e31829b5605","volume":"38","author":"NM Rochet","year":"2015","unstructured":"Rochet NM, Kottschade LA, Grotz TE, Porrata LF, Markovic SN. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma. Am J Clin Oncol. 2015;38(3):252\u20138. https:\/\/doi.org\/10.1097\/COC.0b013e31829b5605.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"12344_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.bjc.6602702","volume":"93","author":"H Schmidt","year":"2005","unstructured":"Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer. 2005;93(3):273\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6602702.","journal-title":"Br J Cancer"},{"key":"12344_CR26","doi-asserted-by":"publisher","unstructured":"Rad Pour S, Pico de Coa\u00f1a Y, Demorentin XM, Melief J, Thimma M, Wolodarski M, et al. Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9\u2009+\u2009monocytes in the blood. J Immunother Cancer. 2021;9(5). https:\/\/doi.org\/10.1136\/jitc-2020-002171.","DOI":"10.1136\/jitc-2020-002171"},{"issue":"2","key":"12344_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jlb.4ri0818-311r","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309\u201322. https:\/\/doi.org\/10.1002\/jlb.4ri0818-311r.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"12344_CR28","doi-asserted-by":"publisher","first-page":"2043673","DOI":"10.1080\/2162402x.2022.2043673","volume":"11","author":"LY Tan","year":"2022","unstructured":"Tan LY, Cockshell MP, Moore E, Myo Min KK, Ortiz M, Johan MZ, et al. Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. Oncoimmunology. 2022;11(1):2043673. https:\/\/doi.org\/10.1080\/2162402x.2022.2043673.","journal-title":"Oncoimmunology"},{"issue":"2","key":"12344_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M","volume":"85","author":"H Torisu","year":"2000","unstructured":"Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer. 2000;85(2):182\u20138.","journal-title":"Int J Cancer"},{"issue":"2","key":"12344_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1158\/1055-9965.epi-21-0591","volume":"31","author":"S Parra-Soto","year":"2022","unstructured":"Parra-Soto S, Malcomson FC, Ho FK, Pell JP, Sharp L, Mathers JC, et al. Associations of a body shape index (ABSI) with Cancer incidence, All-Cause, and at 23 sites-findings from the UK Biobank prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2022;31(2):315\u201324. https:\/\/doi.org\/10.1158\/1055-9965.epi-21-0591.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"12344_CR31","doi-asserted-by":"publisher","unstructured":"Lee JH, Hyung S, Lee J, Choi SH. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J Immunother Cancer. 2022;10(8). https:\/\/doi.org\/10.1136\/jitc-2022-005226.","DOI":"10.1136\/jitc-2022-005226"},{"issue":"2","key":"12344_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cen.13512","volume":"88","author":"DA Delivanis","year":"2018","unstructured":"Delivanis DA, I\u00f1iguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, et al. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018;88(2):209\u201316. https:\/\/doi.org\/10.1111\/cen.13512.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"12344_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1196\/annals.1367.009","volume":"1083","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci. 2006;1083:111\u201328. https:\/\/doi.org\/10.1196\/annals.1367.009.","journal-title":"Ann N Y Acad Sci"},{"key":"12344_CR34","doi-asserted-by":"publisher","unstructured":"Funasaka Y, Sato H, Chakraborty AK, Ohashi A, Chrousos GP, Ichihashi M. Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Investig Dermatol Symp Proc. 1999;4(2):105-9. https:\/\/doi.org\/10.1038\/sj.jidsp.5640192.","DOI":"10.1038\/sj.jidsp.5640192"},{"issue":"2","key":"12344_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1034\/j.1600-0749.2002.1o063.x","volume":"15","author":"H Sato","year":"2002","unstructured":"Sato H, Nagashima Y, Chrousos GP, Ichihashi M, Funasak Y. The expression of corticotropin-releasing hormone in melanoma. Pigment Cell Res. 2002;15(2):98\u2013103. https:\/\/doi.org\/10.1034\/j.1600-0749.2002.1o063.x.","journal-title":"Pigment Cell Res"},{"issue":"5","key":"12344_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1365-2133.2006.07442.x","volume":"155","author":"MH Kim","year":"2006","unstructured":"Kim MH, Cho D, Kim HJ, Chong SJ, Lee KH, Yu DS, et al. Investigation of the corticotropin-releasing hormone-proopiomelanocortin axis in various skin tumours. Br J Dermatol. 2006;155(5):910\u20135. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07442.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"12344_CR37","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1210\/jcem.83.3.4650","volume":"83","author":"A Slominski","year":"1998","unstructured":"Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J. Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab. 1998;83(3):1020\u20134. https:\/\/doi.org\/10.1210\/jcem.83.3.4650.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"12344_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1046\/j.1365-2133.1998.02263.x","volume":"138","author":"M Nagahama","year":"1998","unstructured":"Nagahama M, Funasaka Y, Fernandez-Frez ML, Ohashi A, Chakraborty AK, Ueda M, et al. Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Br J Dermatol. 1998;138(6):981\u20135. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02263.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"12344_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1600-0625.1998.tb00326.x","volume":"7","author":"A Slominski","year":"1998","unstructured":"Slominski A. Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol. 1998;7(4):213\u20136. https:\/\/doi.org\/10.1111\/j.1600-0625.1998.tb00326.x.","journal-title":"Exp Dermatol"},{"key":"12344_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1479-5876-11-72","volume":"11","author":"SL Valles","year":"2013","unstructured":"Valles SL, Benlloch M, Rodriguez ML, Mena S, Pellicer JA, Asensi M, et al. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J Transl Med. 2013;11:72. https:\/\/doi.org\/10.1186\/1479-5876-11-72.","journal-title":"J Transl Med"},{"issue":"3","key":"12344_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1600-079x.1986.tb00749.x","volume":"3","author":"YA Grinevich","year":"1986","unstructured":"Grinevich YA, Labunetz IF. Melatonin, thymic serum factor, and cortisol levels in healthy subjects of different age and patients with skin melanoma. J Pineal Res. 1986;3(3):263\u201375. https:\/\/doi.org\/10.1111\/j.1600-079x.1986.tb00749.x.","journal-title":"J Pineal Res"},{"issue":"1","key":"12344_CR42","first-page":"21","volume":"66","author":"HS Bhakoo","year":"1981","unstructured":"Bhakoo HS, Milholland RJ, Lopez R, Karakousis C, Rosen F. High incidence and characterization of glucocorticoid receptors in human malignant melanoma. J Natl Cancer Inst. 1981;66(1):21\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"12344_CR43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/annonc\/mdm545","volume":"19","author":"MM McCarthy","year":"2008","unstructured":"McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, et al. HSP90 as a marker of progression in melanoma. Ann Oncol. 2008;19(3):590\u20134. https:\/\/doi.org\/10.1093\/annonc\/mdm545.","journal-title":"Ann Oncol"},{"issue":"6","key":"12344_CR44","first-page":"2238","volume":"42","author":"LR Stanberry","year":"1982","unstructured":"Stanberry LR, Das Gupta TK, Beattie CW. Biological behavior of MM1 hamster melanoma. Cancer Res. 1982;42(6):2238\u201341.","journal-title":"Cancer Res"},{"issue":"5","key":"12344_CR45","doi-asserted-by":"publisher","first-page":"e96466","DOI":"10.1371\/journal.pone.0096466","volume":"9","author":"E Obrador","year":"2014","unstructured":"Obrador E, Valles SL, Benlloch M, Sirerol JA, Pellicer JA, Alc\u00e1cer J, et al. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. PLoS ONE. 2014;9(5):e96466. https:\/\/doi.org\/10.1371\/journal.pone.0096466.","journal-title":"PLoS ONE"},{"key":"12344_CR46","doi-asserted-by":"publisher","first-page":"111277","DOI":"10.1016\/j.mce.2021.111277","volume":"530","author":"CS Martins","year":"2021","unstructured":"Martins CS, de Castro M. Generalized and tissue specific glucocorticoid resistance. Mol Cell Endocrinol. 2021;530:111277. https:\/\/doi.org\/10.1016\/j.mce.2021.111277.","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"12344_CR47","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.celrep.2018.02.041","volume":"22","author":"MA Quinn","year":"2018","unstructured":"Quinn MA, Xu X, Ronfani M, Cidlowski JA. Estrogen Deficiency promotes hepatic steatosis via a glucocorticoid receptor-dependent mechanism in mice. Cell Rep. 2018;22(10):2690\u2013701. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.041.","journal-title":"Cell Rep"},{"issue":"7","key":"12344_CR48","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/oby.2005.137","volume":"13","author":"M Duclos","year":"2005","unstructured":"Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res. 2005;13(7):1157\u201366. https:\/\/doi.org\/10.1038\/oby.2005.137.","journal-title":"Obes Res"},{"issue":"9612","key":"12344_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0140-6736(08)60269-x","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569\u201378. https:\/\/doi.org\/10.1016\/s0140-6736(08)60269-x.","journal-title":"Lancet"},{"issue":"7","key":"12344_CR50","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/jcb.25463","volume":"117","author":"P Coelho","year":"2016","unstructured":"Coelho P, Almeida J, Prud\u00eancio C, Fernandes R, Soares R. Effect of Adipocyte Secretome in Melanoma Progression and Vasculogenic Mimicry. J Cell Biochem. 2016;117(7):1697\u2013706. https:\/\/doi.org\/10.1002\/jcb.25463.","journal-title":"J Cell Biochem"},{"issue":"12","key":"12344_CR51","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1210\/jc.2017-01474","volume":"102","author":"N Hetem\u00e4ki","year":"2017","unstructured":"Hetem\u00e4ki N, Savolainen-Peltonen H, Tikkanen MJ, Wang F, Paatela H, H\u00e4m\u00e4l\u00e4inen E, et al. Estrogen Metabolism in Abdominal Subcutaneous and visceral adipose tissue in Postmenopausal Women. J Clin Endocrinol Metab. 2017;102(12):4588\u201395. https:\/\/doi.org\/10.1210\/jc.2017-01474.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"12344_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/annonc\/mdm464","volume":"19","author":"H Gogas","year":"2008","unstructured":"Gogas H, Trakatelli M, Dessypris N, Terzidis A, Katsambas A, Chrousos GP, et al. Melanoma risk in association with serum leptin levels and lifestyle parameters: a case-control study. Ann Oncol. 2008;19(2):384\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdm464.","journal-title":"Ann Oncol"},{"issue":"19","key":"12344_CR53","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.4161\/cbt.8.19.9650","volume":"8","author":"EL Brandon","year":"2009","unstructured":"Brandon EL, Gu JW, Cantwell L, He Z, Wallace G, Hall JE. Obesity promotes melanoma tumor growth: role of leptin. Cancer Biol Ther. 2009;8(19):1871\u20139. https:\/\/doi.org\/10.4161\/cbt.8.19.9650.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"12344_CR54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1523-1747.2001.01422.x","volume":"117","author":"N Kanda","year":"2001","unstructured":"Kanda N, Watanabe S. 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol. 2001;117(2):274\u201383. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01422.x.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"12344_CR55","doi-asserted-by":"publisher","first-page":"e0134396","DOI":"10.1371\/journal.pone.0134396","volume":"10","author":"M Marzagalli","year":"2015","unstructured":"Marzagalli M, Casati L, Moretti RM, Montagnani Marelli M, Limonta P. Estrogen Receptor \u03b2 agonists differentially affect the growth of human melanoma cell lines. PLoS ONE. 2015;10(7):e0134396. https:\/\/doi.org\/10.1371\/journal.pone.0134396.","journal-title":"PLoS ONE"},{"issue":"12","key":"12344_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1600-0625.2006.00502.x","volume":"15","author":"AN Schmidt","year":"2006","unstructured":"Schmidt AN, Nanney LB, Boyd AS, King LE Jr., Ellis DL. Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol. 2006;15(12):971\u201380. https:\/\/doi.org\/10.1111\/j.1600-0625.2006.00502.x.","journal-title":"Exp Dermatol"},{"issue":"1","key":"12344_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archdermatol.2008.537","volume":"145","author":"V de Giorgi","year":"2009","unstructured":"de Giorgi V, Mavilia C, Massi D, Gozzini A, Aragona P, Tanini A, et al. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol. 2009;145(1):30\u20136. https:\/\/doi.org\/10.1001\/archdermatol.2008.537.","journal-title":"Arch Dermatol"},{"key":"12344_CR58","doi-asserted-by":"publisher","unstructured":"Natale CA, Li J, Zhang J, Dahal A, Dentchev T, Stanger BZ, et al. Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. Elife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.31770.","DOI":"10.7554\/eLife.31770"},{"issue":"18","key":"12344_CR59","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1200\/jco.2011.38.0584","volume":"30","author":"A Joosse","year":"2012","unstructured":"Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, et al. Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol. 2012;30(18):2240\u20137. https:\/\/doi.org\/10.1200\/jco.2011.38.0584.","journal-title":"J Clin Oncol"},{"issue":"8","key":"12344_CR60","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.4049\/jimmunol.167.8.4593","volume":"167","author":"H Zarkesh-Esfahani","year":"2001","unstructured":"Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol. 2001;167(8):4593\u20139. https:\/\/doi.org\/10.4049\/jimmunol.167.8.4593.","journal-title":"J Immunol"},{"issue":"2","key":"12344_CR61","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1189\/jlb.3A0914-430RR","volume":"99","author":"V Pelekanou","year":"2016","unstructured":"Pelekanou V, Kampa M, Kiagiadaki F, Deli A, Theodoropoulos P, Agrogiannis G, et al. Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ER\u03b136 and GPR30\/GPER1. J Leukoc Biol. 2016;99(2):333\u201347. https:\/\/doi.org\/10.1189\/jlb.3A0914-430RR.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"12344_CR62","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/bjd.18728","volume":"182","author":"JF Thompson","year":"2020","unstructured":"Thompson JF, Friedman EB. The intriguing association between smoking and reduced melanoma risk. Br J Dermatol. 2020;182(5):1080. https:\/\/doi.org\/10.1111\/bjd.18728.","journal-title":"Br J Dermatol"},{"issue":"3","key":"12344_CR63","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/j.1550-8528.1993.tb00614.x","volume":"1","author":"P Bjorntorp","year":"1993","unstructured":"Bjorntorp P. Visceral obesity: a civilization syndrome. Obes Res. 1993;1(3):206\u201322. https:\/\/doi.org\/10.1002\/j.1550-8528.1993.tb00614.x.","journal-title":"Obes Res"},{"issue":"2","key":"12344_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0021-9150(03)00200-4","volume":"169","author":"MR Smith","year":"2003","unstructured":"Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, et al. Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis. 2003;169(2):331\u20137. https:\/\/doi.org\/10.1016\/s0021-9150(03)00200-4.","journal-title":"Atherosclerosis"},{"issue":"9","key":"12344_CR65","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and Health-related characteristics of UK Biobank participants with those of the General Population. Am J Epidemiol. 2017;186(9):1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12344-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:03:28Z","timestamp":1716447808000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12344"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12344-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted according to the principles expressed in the Declaration of Helsinki. The UK Biobank cohort has been approved by the North West Multicenter Research Ethics Committee, UK (Ref: 16\/NW\/0274). Written informed consent has been obtained from all study participants. The current study was approved by the UK Biobank access management board. Participants who had withdrawn consent by the time of the analysis were excluded from the analysis dataset.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}